NCBiotech News

Atlantic Fish Co. (“AFC”), a food technology company developing premium cultivated seafood, has closed its seed financing round with participation from Katapult Ocean, Alwyn Capital, DMV Capital, the Georgetown Angel Investment Network (GAIN), and other mission-aligned investors.

Frontier Scientific Solutions and Air Transport Services Group Inc. (ATSG) have entered a strategic partnership that creates a dedicated air corridor for life sciences, ensuring continuous temperature control and full shipment integrity from origin to delivery.

Frontier’s Wilmington hub will anchor North American operations, with Shannon, Ireland, leading efforts in Europe, the Middle East and Africa.

Winston-Salem-based BRINTER Inc. has been recognized on TIME Magazine's prestigious "Best Inventions of 2025" list for its groundbreaking work in 3D bioprinted tissue technology. 

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease dermatomyositis. 

Dermatomyositis affects around 50,000 adults in the United States. It can cause progressive muscle weakness and skin rashes, sometimes leading to serious complications such as difficulty swallowing, lung issues or skin damage. 

Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its North American headquarters in Franklinton, N.C., last month for the national flagship Manufacturing Day (MFG Day), a grassroots movement of the Manufacturing Institute (MI).  

Parexel, a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation District. 

Durham-based BioCryst Pharmaceuticals Inc. plans to acquire Boston-based Astria Therapeutics Inc., adding the late-stage hereditary angioedema (HAE) treatment, navenibart, to its portfolio. 

Sooner or later, about one in 10 Americans will experience knee pain, swelling and stiffness, according to a recent scientific paper. The most common diagnosis is osteoarthritis (OA) of the knee, a complex condition caused by multiple factors, including inflammation and wear and tear on these hard-working joints. The cartilage “cushion” that allows the knee to function smoothly erodes, leaving painful bone-on-bone contact. 

In the U.S., about 20 mothers die for every 100,000 live births, with over 10% of these deaths caused by bleeding. The FDA recently cleared HemoSonics LLC’s Quantra Hemostasis System with QStat Cartridge for expanded use in obstetric procedures, giving doctors a new tool to help manage postpartum hemorrhage.

Agriculture represents one-sixth of the North Carolina economy, employing nearly 780,000 people. The state ranks ninth among all states in agricultural production.

With these foundational strengths, North Carolina agribusinesses, farmers and ag technology companies are well-equipped to navigate a variety of challenges, according to speakers at the recent Ag Allies Conference sponsored by the NC Chamber.

Oxford-based Plantd has raised $22 million in venture capital to advance its production of carbon-negative building materials made from fast-growing perennial grass. The Series B funding round “is more than capital ─ it’s momentum,” said Nathan Silvernail, co-founder and chief executive officer of Plantd. "We've proven that sustainability and scalability can grow together, and this next chapter enables us to deliver on a zero-waste vision while creating American manufacturing jobs that drive real climate impact."

Post-pandemic, international biopharmaceutical companies seeking a reliable U.S. supply chain and streamlined production processes rely on contract development and manufacturing organizations (CDMOs). North Carolina’s long-time leadership in the clinical research organizations (CRO) industry makes it a logical place to expand or build facilities, requiring specialized equipment, government-regulated facilities, and a highly educated and trained workforce.

To celebrate 30 years of manufacturing investment, innovation, workforce development and community partnership in North Carolina’s Research Triangle Park (RTP), Biogen leaders and employees hosted a large gathering at the company’s sprawling RTP campus today. The celebration included N.C. Gov. Josh Stein, state and local officials, and multiple members of the biotech community.

Ypsomed AG, a Swiss developer and manufacturer of injection systems for the self-administration of liquid medication, announced plans to invest $249 million (200 million Swiss francs) in the initial phase of establishing its first North American manufacturing facility in Holly Springs, N.C. 

San Diego-based contract research organization (CRO) Crown Bioscience is establishing a new cancer research model development center in Kannapolis.

The global life sciences firm, a wholly owned subsidiary of Japan-based JSR Corporation, said it plans to have its 2,300-square-foot site at the North Carolina Research Campus fully operational in October 2025. Besides its California headquarters, Crown also has another United States facility in Frederick, Maryland.